A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy

Journal of Anatomy

Volumn 207, Issue 6, 2005, Pages 813-821

  Guo, Min ^a   Ricardo, Sharon D ^a   Deane, James A ^a   Shi, Ming ^a   Cullen McEwen, Luise ^a   Bertram, John F ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Capillary length; Db db mouse; Diabetic nephropathy; Glomerular basement membrane thickening; Glomerular hypertrophy; Mesangial expansion; Stereology; Vascular changes

Indexed keywords

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; GLOMERULAR STRUCTURE; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS CAPILLARY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; KIDNEY MASS; LONG TERM CARE; MESANGIUM CELL; MICROVASCULATURE; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; STEREOLOGY;

ANIMALS; BODY WEIGHT; CAPILLARIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; GLOMERULAR MESANGIUM; KIDNEY GLOMERULUS; MICE; MICE, MUTANT STRAINS; MICROSCOPY, ELECTRON; POINT MUTATION; RECEPTORS, CELL SURFACE;

ANIMALIA;

EID: 29644434152     PISSN: 00218782     EISSN: 14697580     Source Type: Journal    
DOI: 10.1111/j.1469-7580.2005.00492.x     Document Type: Article

References (39)

1. Bertram JF (1995) Analyzing renal glomeruli with the new stereology. Int Rev Cytol 161, 111-172.
2. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820.
3. Cahill MM, Ryan GB, Bertram JF (1996) Biphasic glomerular hypertrophy in rats administered puromycin aminonucleoside. Kidney Int 50, 768-775.
4. Cooper ME, Vranes D, Youssef S, et al. (1999) Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 48, 2229-2239.
5. Doi T, Striker LJ, Gibson CG, Agodoa LYC, Brinster RL, Striker GE (1990) Glomerular lesions in mice transgenic for growth hormone and insulin-like growth factor-1. Am J Pathol 137, 541-552.
6. Flyvberg A, Dagnaes-Hansen F, De Vriese AS, Schrijvers BF, Tilton RG, Rasch R (2002) Amelioration of long-term renal changes in obese Type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 51, 3090-3094.
7. Fogo A, Hawkins EP, Berry PL, et al. (1990) Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int 38, 115-123.
8. Gilbert RE, Cooper ME (1999) The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 56, 1627-1637.
9. Gundersen HJ, Bendtsen TF, Korbo L, et al. (1988a) Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96, 379-394.
10. Gundersen HJ, Bagger P, Benstsen TF, et al. (1988b) The new stereological tools: dissector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96, 857-881.
11. Guo M, Chrisrensen S, Marcussen N, Osterby R (2000) Glomerular structure in lithium-induced chronic renal failure in rats. APMIS 108, 652-662.
12. Hirose K, Osterby R, Nozawa M, Gundersen HJ (1982) Development of glomerular lesion in experimental long-term diabetes in the rat. Kidney Int 21, 689-695.
13. Hummel KP, Coleman DL, Lane PW (1971) The influence of genetic background on expression of mutations at the diabetes focus in the mouse. I C57BL/KsJ and C57BL/6J strains. Biochem Genet 7, 1-13.
14. Koya D, Haneda M, Nakagawa H, et al. (2000) Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC-β inhibitor in diabetic db/db mice, a rodent model for Type 2 diabetes. FASEB 14, 439-447.
15. Kroustrup JP, Gundersen HJ, Osterby R (1977) Glomerular size and structure in diabetes mellitus. III. Early enlargement of the capillary surface. Diabetologia 13, 207-210.
16. Like AA, Lavine RL, Poffenbarger PI, Chick WL (1972) Studies in the diabetic mutant mouse. VI. Evolution of glomerular lesions and associated proteinuria. Am J Pathol 66, 193-224.
17. Maisonpierre PC, Suri C, Jones PF, et al. (1997) Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis. Science 277, 55-60.
18. Mason RM, Wahab NA (2003) Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 14, 1358-1373.
19. McKay K, Striker LJ, Pinkert CA, Brinster RL, Striker GE (1990) Relationship of glomerular hypertrophy and sclerosis: studies in SV40 transgenic mice. Kidney Int 37, 741-748.
20. Mogensen CE, Andersen MJ (1973) Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 22, 706-712.
21. Moriya T, Tanaka K, Moriya R (2000) Glomerular structural changes and structural-functional relationships at early stage of diabetic nephropathy in Japanese Type 2 diabetic patients. Med Electron Microsc 32, 115-122.
22. Nagata M, Scharer K, Kriz W (1992) Glomerular damage after uninephrectomy in young rats. I. Hypertrophy and distortion of capillary architecture. Kidney Int 42, 136-147.
23. Nishikawa T, Edelstein D, Liang XD, et al. (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 404, 787-790.
24. Nyengaard JR, Rasch R (1993) The impact of experimental diabetes mellitus in rats on capillary number and sizes. Diabetologia 36, 189-194.
25. Osterby R, Gundersen HJG (1980) Fast accumulation of basement membrane material and the rate of morphological changes in acute experimental diabetic glomerular hypertrophy. Diabetologia 18, 493-500.
26. Osterby R (1992) Glomerular structural changes in Type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention. Diabetologia 35, 803-812.
27. Osterby R, Bangstad HJ, Nyberg G, Rudberg S (2001) On glomerular structural alterations in Type 1 diabetes. Companions of early diabetic nephropathy. Virchows Arch 438, 129-135.
28. Ramage IJ, Howatson AG, McColl JH, Maxwell H, Murphy AV, Beattie TJ (2002) Glomerular basement membrane thickness in children: a stereological assessment. Kidney Int 62, 895-900.
29. Remuzzi G, Schieppati A, Ruggenenti P (2002) Nephropathy in patients with Type 2 diabetes. N Eng J Med 346, 1145-1151.
30. Sharma K, McCue P, Dunn SR (2003) Diabetic kidney disease in the db/db mouse. Am J Physiol 284, F1138-F1144.
31. Steffes MW, Osterby R, Chavers B, Mauer SM (1993) Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetologia 36, 1064-1070.
32. Suri C, Jones PF, Patan S, et al. (1996) Requisite role of angiopoietin-1, a ligand for TIE-2 receptor, during embryonic angiogenesis. Cell 87, 55-60.
33. Tsuchida K, Makita Z, Yamagishi S, et al. (1999) Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195. Diabetologia 42, 579-588.
34. Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH (2001) Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 12, 993-1000.
35. Wei P, Lane PH, Lane JT, Padanilam BJ, Sansom SC (2004) Glomerular structural and functional changes in a high-fat diet mouse model if early-stage Type 2 diabetes. Diabetologia 47, 1541-1549.
36. Woolf AS, Yuan HT (2001) Angiopoietin growth factors and Tie receptor tyrosine kinases in renal vascular development. Pediatr Nephrol 16, 177-184.
37. Yamamoto Y, Maeshima Y, Kitayama H, et al. (2004) Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy. Diabetes 53, 1831-1840.
38. Yoshida H, Fogo A, Ichikawa I (1989) Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis. Kidney Int 35, 654-660.
39. Ziyadeh FN, Hoffman BB, Han DC, et al. (2000) Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal anti-TGF-β antibody in db/db diabetic mice. Proc Natl Acad Sci USA 97, 8015-8020.